Publications

• Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma.

  (Jariwalla NR, Khan AH, Dua K, Christians KK, Clarke CN, Aldakkak M, George B, Tutton S, Rilling W, Erickson B, Evans DB, Tsai S.) Ann Surg Oncol. 2019 Dec;26(13):4515-4521 PMID: 31641946 SCOPUS ID: 2-s2.0-85074492297 10/24/2019

• Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery.

  (Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, Dua K, Clarke CN, Tolat P, Hagen C, Hall WA, Erickson BA, Evans DB, Christians KK.) Surgery. 2019 09;166(3):277-285 PMID: 31272811 SCOPUS ID: 2-s2.0-85068174272 07/06/2019

• RAS Mutation Status Confers Prognostic Relevance in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.

  (Morgan Z, Chow BE, Strong EA, Tsai S, Christians K, Mogal H, Gamblin TC, Clarke CN.) J Surg Res. 2019 08;240:130-135 PMID: 30928770 SCOPUS ID: 2-s2.0-85063410472 04/01/2019

• Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.

  (Silva JP, Maurina MN, Tsai S, Christians KK, Clarke CN, Mogal H, Saeian K, Gamblin TC.) J Am Coll Surg. 2019 03;228(3):245-254 PMID: 30639515 SCOPUS ID: 2-s2.0-85060157296 01/15/2019

• Distal splenorenal and mesocaval shunting at the time of pancreatectomy.

  (Chavez MI, Tsai S, Clarke CN, Aldakkak M, Griffin MO, Khan AH, Ritch PS, Erickson BA, Evans DB, Christians KK.) Surgery. 2019 02;165(2):298-306 PMID: 30471779 SCOPUS ID: 2-s2.0-85056892124 11/26/2018

• Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative.

  (Wilkinson KH, Ethun CG, Hembrook M, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Weber S, Gamblin TC, Cardona K, Clarke CN.) J Surg Res. 2019 01;233:154-162 PMID: 30502242 SCOPUS ID: 2-s2.0-85051762456 12/07/2018

• Elective Regional Therapy Treatment for Hepatic Adenoma.

  (Silva JP, Klooster B, Tsai S, Christians KK, Clarke CN, Mogal H, Clark Gamblin T.) Ann Surg Oncol. 2019 Jan;26(1):125-130 PMID: 30353390 SCOPUS ID: 2-s2.0-85055702464 10/26/2018

• A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma.

  (Tsai S, Christians KK, George B, Ritch PS, Dua K, Khan A, Mackinnon AC, Tolat P, Ahmad SA, Hall WA, Erickson BA, Evans DB.) Ann Surg. 2018 10;268(4):610-619 PMID: 30080723 SCOPUS ID: 2-s2.0-85067054610 08/07/2018

• Gallbladder carcinoma: An analysis of the national cancer data base to examine hispanic influence.

  (Liu C, Berger NG, Rein L, Tarima S, Clarke C, Mogal H, Christians KK, Tsai S, Gamblin TC.) J Surg Oncol. 2018 Jun;117(8):1664-1671 PMID: 29714811 SCOPUS ID: 2-s2.0-85046125870 05/02/2018

• Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice?

  (Krepline AN, Bliss L, Geurts J, Akinola I, Christians KK, George B, Ritch PS, Hall WA, Erickson BA, Evans DB, Tsai S.) J Gastrointest Surg. 2019 Nov 19 PMID: 31745905 SCOPUS ID: 2-s2.0-85076028351 11/21/2019

• Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy.

  (Coon C, Berger N, Eastwood D, Tsai S, Christians K, Mogal H, Clarke C, Gamblin TC.) Ann Surg Oncol. 2019 Nov 01 PMID: 31677109 SCOPUS ID: 2-s2.0-85074715626 11/05/2019

• Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer.

  (Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB.) Ann Surg. 2018 Oct 11 PMID: 30312198 10/13/2018